tiprankstipranks
Trending News
More News >
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989)
:9989
Hong Kong Market
9989
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H
RESEARCH TOOLSreports

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (9989) Ownership - Who Owns Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H?

Compare
1 Followers

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (9989) Ownership Overview

0.36%0.33%99.31%
0.36%
Mutual Funds
0.33% ETFs
99.31% Public Companies and
Individual Investors
The ownership structure of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989) stock is a mix of institutional, retail, and individual investors. , and 99.31% is owned by Public Companies and Individual Investors.
The ownership structure of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989) stock is a mix of institutional, retail, and individual investors. Approximately 99.64% of the company’s stock is owned by Institutional Investors, 0.36% is owned by Insiders

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
686,000Institution0.31%392,392
457,000Institution0.21%261,404
316,000Institution0.14%180,752
49,000Institution0.02%28,028
20,000Institution<0.01%11,440

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
457,000Institution0.21%261,404
316,000Institution0.14%180,752
20,000Institution<0.01%11,440

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
457,000Institution0.21%262,436
49,000Institution0.02%27,414
20,000Institution<0.01%11,485

FAQ

Who Owns Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989)?
Currently, no data Available
What percentage of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989) stock is held by institutional investors?
Currently, no data Available
What percentage of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.31% of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989) stock is held by retail investors.
    Who owns the most shares of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989)?
    Vanguard owns the most shares of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989).
      What is the significance of the ownership structure for a publicly traded company?
      The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis